Topic Menu
► Topic MenuTopic Editors

2. Department of Dermatology, Virgen del Rocio University Hospital, 41013 Sevilla, Spain

Epidemiology and Risk Factors of Skin Cancer

Topic Information
Dear Colleagues,
Skin cancer is the most frequent oncological diagnosis worldwide. The global prevalence of melanoma has increased from 0.02% in 1990 to 0.03% in 2017. On the other hand, the prevalence of non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) has increased from 0.01% in 1990 to 0.03% in 2017. Despite numerous efforts and campaigns on promotion and prevention strategies, its incidence, prevalence, and disability-adjusted life years continue to increase. The constant increase in the prevalence and morbidity of skin cancer in recent decades is a current epidemiological challenge, which is why it is essential to promote community participation and empowerment and to develop and disseminate new and promising preventive strategies. Exposure to ultraviolet radiation is the most important modifiable environmental risk factor for the development of skin cancer. However, it is clear that this is not the only contributing factor. Having knowledge of global incidence and prevalence, determining new risk factors, and better characterizing known factors are essential in a health problem such as skin cancer.
In this topic, we focus on the current state of knowledge on the epidemiology and risk factors of skin cancer, both melanoma and non-melanoma, including not only basal cell carcinoma and squamous cell carcinoma but also other less-prevalent cancers such as Merkel cell carcinoma.
The topic Epidemiology and Risk Factors of Skin Cancer provides a platform to publish manuscripts from different disciplines including exposure assessment science, epidemiology, intervention studies, and risk and health impact assessment, as well as population studies, big data studies, and studies on the application of artificial intelligence in this field. We preferably seek new research papers and systematic reviews, although other types of contributions such as narrative reviews, case series, brief reports, etc., may also be considered.
Dr. José Juan Pereyra-Rodríguez
Dr. Ricardo Ruiz-Villaverde
Prof. Dr. Jose-Carlos Armario-Hita
Topic Editors
Keywords
- dermatology
- skin cancer
- epidemiology
- technology
- big data
- artificial intelligence
- risk factors
- solar exposition
- pollution
- microorganisms
- infectious diseases
- health impact
- emerging contaminants
- exposure assessment
- risk assessment
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Biomedicines
|
3.9 | 5.2 | 2013 | 14.6 Days | CHF 2600 |
![]()
Cancers
|
4.5 | 8.0 | 2009 | 17.4 Days | CHF 2900 |
![]()
Clinics and Practice
|
1.7 | 2.6 | 2011 | 20.8 Days | CHF 1600 |
![]()
Dermato
|
- | - | 2021 | 37.6 Days | CHF 1000 |
![]()
Life
|
3.2 | 4.3 | 2011 | 17.8 Days | CHF 2600 |
![]()
Current Oncology
|
2.8 | 3.3 | 1994 | 19.8 Days | CHF 2200 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.